Skip to content
The Nexus
DossierENTITY

Daniel Gross

Coverage of Daniel Gross in the Nexus archive.

Earliest in view: Jun 2 · 17:00 UTCMost recent: Jun 2 · 17:00 UTC
Co-mentioned in this coverage
NewLimitorganization1Founders Fundorganization1Thrive Capitalorganization1Lilly Venturesorganization1Brian Armstrongperson1Blake Byersperson1Jacob Kimmelperson1Nat Friedmanperson1
Recent coverage
  • BUSINESSJun 2 · 17:00 UTCSTAT NEWS
    STAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trial

    Longevity startup NewLimit raised $435 million in a Series C funding round led by Founders Fund, Thrive Capital, Lilly Ventures, and tech entrepreneurs Nat Friedman and Daniel Gross. The company, founded in 2021 by Brian Armstrong, Blake Byers, and Jacob Kimmel, plans to launch its first clinical trial of a liver medicine and is now valued at $3.1 billion.

Daniel Gross · Dossier · The Nexus